DNLI and MRNA Related Headlines
Go Back- Flagship Appoints Amy O'Shea as CEO-Partner and Chief Executive Officer of Invaio Sciences
- Flagship Pioneering Named to Fast Company's Annual List of the World's Most Innovative Companies of 2024
- DEAN BANKS APPOINTED CEO OF INDIGO AG AND CEO-PARTNER OF FLAGSHIP PIONEERING
- Flagship Pioneering and Samsung Announce Collaboration to Advance Groundbreaking Technologies in Translational Science and Medicine
- Flagship Pioneering Debuts Enabling Technologies Initiative
- Sail Biomedicines Provides Update on Research with Cystic Fibrosis Foundation and Pioneering Medicines
- Thermo Fisher Scientific & Flagship Pioneering Expand Ongoing Strategic Partnership to Jointly Create New Platform Companies with First-in-Class Enabling Technologies for Life Sciences
- Flagship Pioneering Marks Official Opening of UK Hub with Event Convening Life Science Leaders
- Flagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of Genetics
- Flagship Pioneering Launches Pioneering Intelligence
- Flagship Pioneering Announces the Merger of Two Leading Programmable Medicine Platforms to Form Sail Biomedicines
- Flagship Pioneering Appoints John Lepore as CEO-Partner and CEO of ProFound Therapeutics
- Flagship Pioneering Named to Fortune's 2023 "Change the World" List
- ProFound Therapeutics Expands Leadership Team With Appointment of Klaus Urbahns as Chief Scientific Officer
- Flagship Pioneering Announces Appointment of Amanda Kay as Chief Business Development Officer
- Invaio achieves first registration for citrus greening solution featuring Trecise™ technology
- Flagship Pioneering Announces Appointment of David Khougazian as Growth Partner
- Alltrna Expands Leadership Team with Appointments of Chief Scientific Officer and Chief Technology Officer
- Flagship Pioneering Appoints Jason Gardner as CEO-Partner and CEO of Ampersand Biomedicines
- Alltrna Announces Series B Raise of $109 Million to Advance tRNA Medicines for Stop Codon Disease
- Alltrna Engineers tRNA Oligonucleotide with Improved Potency and Activity for In Vivo Readthrough of Premature Termination Codons
- Flagship Pioneering Launches Metaphore Biotechnologies to Unlock the Therapeutic Potential of Biomimicry
DNLI and MRNA Related Press Releases
Go Back- Flagship Appoints Amy O'Shea as CEO-Partner and Chief Executive Officer of Invaio Sciences
- Flagship Pioneering Named to Fast Company's Annual List of the World's Most Innovative Companies of 2024
- DEAN BANKS APPOINTED CEO OF INDIGO AG AND CEO-PARTNER OF FLAGSHIP PIONEERING
- Flagship Pioneering and Samsung Announce Collaboration to Advance Groundbreaking Technologies in Translational Science and Medicine
- Flagship Pioneering Debuts Enabling Technologies Initiative
- Sail Biomedicines Provides Update on Research with Cystic Fibrosis Foundation and Pioneering Medicines
- Thermo Fisher Scientific & Flagship Pioneering Expand Ongoing Strategic Partnership to Jointly Create New Platform Companies with First-in-Class Enabling Technologies for Life Sciences
- Flagship Pioneering Marks Official Opening of UK Hub with Event Convening Life Science Leaders
- Flagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of Genetics
- Flagship Pioneering Launches Pioneering Intelligence
- Flagship Pioneering Announces the Merger of Two Leading Programmable Medicine Platforms to Form Sail Biomedicines
- Flagship Pioneering Appoints John Lepore as CEO-Partner and CEO of ProFound Therapeutics
- Flagship Pioneering Named to Fortune's 2023 "Change the World" List
- ProFound Therapeutics Expands Leadership Team With Appointment of Klaus Urbahns as Chief Scientific Officer
- Flagship Pioneering Announces Appointment of Amanda Kay as Chief Business Development Officer
- Invaio achieves first registration for citrus greening solution featuring Trecise™ technology
- Flagship Pioneering Announces Appointment of David Khougazian as Growth Partner
- Alltrna Expands Leadership Team with Appointments of Chief Scientific Officer and Chief Technology Officer
- Flagship Pioneering Appoints Jason Gardner as CEO-Partner and CEO of Ampersand Biomedicines
- Alltrna Announces Series B Raise of $109 Million to Advance tRNA Medicines for Stop Codon Disease
- Alltrna Engineers tRNA Oligonucleotide with Improved Potency and Activity for In Vivo Readthrough of Premature Termination Codons
- Flagship Pioneering Launches Metaphore Biotechnologies to Unlock the Therapeutic Potential of Biomimicry
